Brief: Orexo Converts Future Rights For OX-MPI To Shares In Gesynta Pharma Valued At SEK 19 Mln
Jan 20 (Reuters) - Orexo AB ORX.ST :
* CONVERTS FUTURE RIGHTS FOR OX-MPI TO SHARES IN GESYNTA
PHARMA
VALUED AT SEK 19 MILLION
Source text: ID:nMFN59N756
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens